Logo image of ALHEX.PA

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

Europe - EPA:ALHEX - FR0004159473 - Common Stock

27.6 EUR
-0.1 (-0.36%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALHEX scores 4 out of 10 in our fundamental rating. ALHEX was compared to 32 industry peers in the Household Durables industry. The financial health of ALHEX is average, but there are quite some concerns on its profitability. ALHEX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALHEX was profitable.
In the past year ALHEX had a positive cash flow from operations.
Of the past 5 years ALHEX 4 years were profitable.
ALHEX had a positive operating cash flow in each of the past 5 years.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

ALHEX's Return On Assets of 2.48% is in line compared to the rest of the industry. ALHEX outperforms 59.38% of its industry peers.
With a Return On Equity value of 6.20%, ALHEX perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
The Return On Invested Capital of ALHEX (6.12%) is comparable to the rest of the industry.
ALHEX had an Average Return On Invested Capital over the past 3 years of 8.77%. This is in line with the industry average of 9.97%.
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROIC 6.12%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ALHEX has a Profit Margin of 1.94%. This is comparable to the rest of the industry: ALHEX outperforms 53.13% of its industry peers.
ALHEX's Profit Margin has declined in the last couple of years.
ALHEX has a worse Operating Margin (2.79%) than 62.50% of its industry peers.
In the last couple of years the Operating Margin of ALHEX has declined.
ALHEX has a Gross Margin of 19.40%. This is amonst the worse of the industry: ALHEX underperforms 87.50% of its industry peers.
ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALHEX is creating some value.
ALHEX has about the same amout of shares outstanding than it did 1 year ago.
ALHEX has a better debt/assets ratio than last year.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALHEX has an Altman-Z score of 2.47. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.47, ALHEX perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
The Debt to FCF ratio of ALHEX is 9.35, which is on the high side as it means it would take ALHEX, 9.35 years of fcf income to pay off all of its debts.
ALHEX has a Debt to FCF ratio (9.35) which is in line with its industry peers.
A Debt/Equity ratio of 0.24 indicates that ALHEX is not too dependend on debt financing.
ALHEX has a Debt to Equity ratio of 0.24. This is in the better half of the industry: ALHEX outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Altman-Z 2.47
ROIC/WACC0.91
WACC6.73%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.30 indicates that ALHEX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.30, ALHEX is doing worse than 65.63% of the companies in the same industry.
ALHEX has a Quick Ratio of 1.01. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALHEX (1.01) is better than 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.01
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for ALHEX have decreased strongly by -56.88% in the last year.
Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
Looking at the last year, ALHEX shows a very negative growth in Revenue. The Revenue has decreased by -28.88% in the last year.
ALHEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.93% yearly.
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%

3.2 Future

The Earnings Per Share is expected to grow by 37.93% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y32.2%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.33, which indicates a correct valuation of ALHEX.
Based on the Price/Earnings ratio, ALHEX is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.20. ALHEX is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.89, the valuation of ALHEX can be described as very reasonable.
ALHEX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. ALHEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.33
Fwd PE 9.89
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than ALHEX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 22
EV/EBITDA 2.76
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

ALHEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALHEX's earnings are expected to grow with 37.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

ALHEX has a Yearly Dividend Yield of 1.81%.
Compared to an average industry Dividend Yield of 4.90, ALHEX has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.38, ALHEX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

HEXAOM

EPA:ALHEX (9/17/2025, 7:00:00 PM)

27.6

-0.1 (-0.36%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-07 2025-05-07
Earnings (Next)09-24 2025-09-24
Inst Owners13.9%
Inst Owner ChangeN/A
Ins Owners2.81%
Ins Owner ChangeN/A
Market Cap191.54M
Analysts86.67
Price Target41.31 (49.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)9.05%
EPS NY rev (3m)9.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.33
Fwd PE 9.89
P/S 0.26
P/FCF 22
P/OCF 12.58
P/B 0.84
P/tB 1.41
EV/EBITDA 2.76
EPS(TTM)2.07
EY7.5%
EPS(NY)2.79
Fwd EY10.11%
FCF(TTM)1.25
FCFY4.55%
OCF(TTM)2.19
OCFY7.95%
SpS104.97
BVpS32.84
TBVpS19.59
PEG (NY)0.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROCE 7.89%
ROIC 6.12%
ROICexc 12.79%
ROICexgc 39.35%
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
FCFM 1.2%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexcg growth 3Y-17.24%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Debt/EBITDA 1.55
Cap/Depr 43.08%
Cap/Sales 0.9%
Interest Coverage 250
Cash Conversion 42.9%
Profit Quality 61.63%
Current Ratio 1.3
Quick Ratio 1.01
Altman-Z 2.47
F-Score6
WACC6.73%
ROIC/WACC0.91
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
EPS Next Y32.2%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-41.69%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.7%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-65.3%
OCF growth 3Y-21.91%
OCF growth 5YN/A